Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection
<p>HCV infects 170 million persons worldwide and is a serious global health problem. Genotype-3a is the dominant genotype in newly diagnosed infections within the UK and has a high response rate to interferon therapy, with up to 70% patients achieving a sustained virological response (SVR). Th...
Asıl Yazarlar: | Humphreys, I, Isla S. Humphreys |
---|---|
Diğer Yazarlar: | Barnes, E |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2011
|
Konular: |
Benzer Materyaller
-
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
Yazar:: Hennig, B, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
Yazar:: Antrobus, R
Baskı/Yayın Bilgisi: (2014) -
Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
Yazar:: Gupta, P
Baskı/Yayın Bilgisi: (2014) -
Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
Yazar:: Kelly, C
Baskı/Yayın Bilgisi: (2013) -
Aspects to T-cell phenotype during infection with HIV, CMV and Hepatitis C virus
Yazar:: Northfield, J
Baskı/Yayın Bilgisi: (2008)